<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>CX-5461 Immunogenomics Portfolio</title>
    <link rel="stylesheet" href="style.css">
    <link rel="preconnect" href="https://fonts.googleapis.com">
    <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
    <link href="https://fonts.googleapis.com/css2?family=Inter:wght@400;600;800&display=swap" rel="stylesheet">
</head>
<body>
    <header>
        <div class="container">
            <h1>CX-5461 Immunogenomics Workflow</h1>
            <p class="subtitle">A framework for systematic neoantigen prediction and biomarker discovery in HRD-high breast cancer, scalable to colorectal cancer (CRC) applications.</p>
            <div class="badges">
                <span class="step-badge" style="background: #10b981;">Breast Cancer Optimized</span>
                <span class="step-badge" style="background: #4f46e5;">Scalable to CRC</span>
            </div>
        </div>
    </header>

    <main class="container">
        <section class="intro card">
            <h3>Overview</h3>
            <p>This project demonstrates a 4-step computational pipeline that models neoantigen generation following <strong>CX-5461</strong> induced stress. By integrating public data (TCGA, COSMIC) with experimental signatures (GSE), the framework identifies conserved biomarkers and high-affinity epitopes for chemo-immunotherapy combination strategies.</p>
        </section>

        <div class="card-grid">
            <!-- Step 1 -->
            <div class="card">
                <span class="step-badge">Phase 01</span>
                <h3>Data Acquisition</h3>
                <p>Retrieval of TCGA-BRCA cohorts (N~1,100) using GDC API, focused on HRD-high populations sensitive to G-quadruplex stabilizers.</p>
                <pre><code>GDCquery(
  project = "TCGA-BRCA",
  data.category = "Transcriptome"
)</code></pre>
            </div>

            <!-- Step 2 -->
            <div class="card">
                <span class="step-badge">Phase 02</span>
                <h3>Predictive Modeling</h3>
                <p>Simulation of collateral mutagenesis using the <strong>SBS-CX-5461</strong> signature. Prediction of MHC binding via NetMHCpan-4.1.</p>
                <pre><code>netMHCpan -p peptides.txt \
-a HLA-A*02:01 -BA</code></pre>
            </div>

            <!-- Step 3 -->
            <div class="card">
                <span class="step-badge">Phase 03</span>
                <h3>Multi-Omics Integration</h3>
                <p>Correlating predicted epitopes with experimental CX-5461 RNA-seq data to prioritize upregulated, high-affinity candidates.</p>
                <div class="viz-box"></div>
            </div>

            <!-- Step 4 -->
            <div class="card">
                <span class="step-badge">Phase 04</span>
                <h3>Deep Learning</h3>
                <p>Ensemble ML approach (NeoPredictor) integrating peptide sequences and HRD scores for immunogenicity ranking.</p>
                <pre><code># PyTorch NeoPredictor
combined = torch.cat((seq, feat))
return classifier(combined)</code></pre>
            </div>
        </div>

        <section class="results">
            <h3>Simulated Results: Prioritized Neoantigens</h3>
            <div class="table-wrapper">
                <table>
                    <thead>
                        <tr>
                            <th>Gene Target</th>
                            <th>Modification</th>
                            <th>Affinity (nM)</th>
                            <th>Expression (log2FC)</th>
                            <th>Priority Score</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td>BRCA1</td>
                            <td>T > A (ATA)</td>
                            <td>12.8</td>
                            <td>+2.4</td>
                            <td><span style="color: #10b981;">High</span></td>
                        </tr>
                        <tr>
                            <td>TP53</td>
                            <td>T > C (ATG)</td>
                            <td>45.2</td>
                            <td>+1.8</td>
                            <td><span style="color: #10b981;">High</span></td>
                        </tr>
                        <tr>
                            <td>PIK3CA</td>
                            <td>T > A (ATA)</td>
                            <td>510.5</td>
                            <td>-0.2</td>
                            <td><span style="color: #94a3b8;">Medium</span></td>
                        </tr>
                    </tbody>
                </table>
            </div>
        </section>
    </main>

    <footer>
        <div class="container">
            <p>&copy; 2026 Portfolio Project - Advanced Immunogenomics Analysis</p>
            <p style="font-size: 0.8rem; margin-top: 1rem;">This pipeline is designed for researchers at the intersection of DNA damage response and immunotherapy.</p>
        </div>
    </footer>
</body>
</html>
